首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1584113

E型肝炎診斷測試市場，按產品類型、最終用途、國家和地區 - 2024-2032年產業分析、市場規模、市場佔有率和預測

Hepatitis E Diagnostic Tests Market, By Product Type, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年10月26日 | 出版商:

AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

報告要點

2023年E型肝炎診斷測試市場規模為 5,352萬美元，2024年至2032年年複合成長率為 4.80%。

E型肝炎診斷測試市場-市場動態

早期診斷和及時治療的需求不斷增加，以推動市場需求

近年來，全球E型肝炎診斷市場經歷了重大的技術進步，提高了診斷解決方案的準確性、效率和可近性。例如，2021年 6月，DiaSorin 推出了用於E型肝炎診斷的全自動高通量 CLIA 解決方案，可在接受 CE 標誌的國家使用。這項新產品代表了E型肝炎診斷的重要改進，使醫療保健提供者能夠有效地進行高通量檢測。這種能力在E型肝炎高流行地區尤其重要，在這些地區，快速識別感染者對於有效的疾病管理和預防非常重要。此類先進診斷平台的推出滿足了對準確、高效測試解決方案不斷成長的需求。努力提高醫療保健提供者、高風險族群和公眾的意識對於推動市場成長也非常重要。人們對E型肝炎的風險和後果（包括孕婦死亡率較高）的認知不斷提高，推動了對準確診斷測試的需求。將E型肝炎檢測納入世界衛生組織2023年基本診斷清單，突顯了全球對該疾病早期檢測和管理重要性的認知。政府和醫療保健系統越來越認知到需要改進監測和疫情管理，增加了 HEV 診斷套件的採購。此外，患者和臨床醫生尋求更佳獲得E型肝炎檢測，以實現早期診斷和及時治療，進一步推動市場成長。例如，印度政府全面的國家病毒性肝炎控制計劃目的是透過注重預防、診斷和治療的多管齊下的方法，解決包括E型肝炎在內的所有形式的病毒性肝炎的負擔。該計劃包括大量政府資金和分散實施策略，以增強醫療保健系統有效管理病毒性肝炎的能力。醫療保健支出的增加，特別是在新興市場，也支持了市場的成長。對早期檢測和有效疾病管理的重視推動對診斷測試的需求。隨著人們對E型肝炎的認知不斷提高，人們更加重視實施預防措施，包括個人衛生、安全水源、適當的衛生設施和食品安全，以減輕病毒的傳播。

E型肝炎診斷測試市場 - 關鍵見解

根據研究分析師分享的分析，預計全球市場在預測期內（2024-2032年）每年將以 4.80%左右的年複合成長率成長

根據產品類型細分，預計 ELISA HEV IgM 測試將在2023年顯示最大的市場佔有率

根據最終用途細分，2023年醫院是領先類型

依地區分類，北美是2023年的主要收入來源

E型肝炎診斷測試市場-細分分析：

全球E型肝炎診斷測試市場根據產品類型、最終用途和地區進行細分。

根據產品類型，市場分為四類：ELISA HEV IgM 測試、ELISA HEV IgG 測試、快速診斷測試和聚合酶鏈反應（PCR）。根據類型，ELISA HEV IgM 測試領域在2023年以最大的收入佔有率引領E型肝炎診斷測試市場。發揮關鍵作用。 IgM 抗體的存在對於診斷急性E型肝炎非常重要，通常透過後續 RNA 檢測來證實。基於 ELISA 的IgM 檢測的高靈敏度和特異性使其成為初次 HEV 篩檢的首選。例如，Dia.Pro 提供 HEV-IgM ELISA 檢測試劑盒，專門用於檢測人類血清或血漿中針對 HEV 的IgM 抗體。E型肝炎感染發生率不斷上升，特別是在環境衛生和個人衛生習慣不足的發展中地區，顯著增加了對 ELISA HEV IgM 檢測等有效診斷工具的需求。

根據最終用途，市場分為四大類：醫院、血庫、診斷實驗室和其他最終用戶。就最終用途而言，醫院細分市場在2023年以最大的收入佔有率引領市場。醫院配備了先進的診斷設施、各種醫療保健專業人員以及有效診斷和管理E型肝炎病例的必要基礎設施。此外，醫院經常充當更複雜病例的轉診中心，進一步提高其在全球市場中的顯著收入佔有率。

E型肝炎診斷測試市場 - 地理洞察

該市場迎合了地理上分散的客戶群，涵蓋北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些地區的參與國家在市場內創造細分市場。2023年，北美E型肝炎診斷測試市場佔據重要佔有率。此外，政府對傳染病診斷研究和開發的舉措和資助透過促進新診斷解決方案的開發和採用而有助於市場成長。例如，2024年4月，明尼蘇達大學荷美爾研究所的Susan Hafenstein 博士從全國兒童醫院獲得了85,000 美元的NIH 資助，以支持她對HEV 的冷凍電鏡研究，目標是為HEV 制定新的治療和預防策略。

E型肝炎診斷測試市場-競爭格局：

E型肝炎診斷測試市場的公司採用各種策略來增強競爭力並擴大市場範圍。強調研究和開發非常重要，重點是提高測試靈敏度和特異性，以及創建快速和即時測試解決方案。與醫療機構和實驗室的策略合作有助於促進臨床驗證並促進新測試的廣泛採用。行銷策略強調早期檢測在預防併發症方面的重要性，特別是針對醫療保健提供者和公共衛生機構。此外，公司經常進行教育活動，以提高人們對E型肝炎風險和檢測可用性的認知，確保診斷成為肝臟健康管理不可或缺的一部分。

介紹
- 依地理位置分類的細分市場佔有率分析
北美洲
- 概述
- E型肝炎診斷測試北美主要製造商
- 北美市場規模和預測（依國家）
- 北美市場規模和預測（依產品類型）
- 北美市場規模和預測（依最終用途）
- 美國
- 加拿大
歐洲
- 概述
- E型肝炎診斷測試歐洲主要製造商
- 歐洲市場規模和預測（依國家）
- 歐洲市場規模和預測（依產品類型）
- 歐洲市場規模和預測（依最終用途）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區（APAC）
- 概述
- E型肝炎診斷測試亞太地區主要製造商
- 亞太地區市場規模與預測（依國家）
- 亞太地區市場規模與預測（依產品類型）
- 亞太地區市場規模和預測（依最終用途）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- E型肝炎診斷測試拉丁美洲主要製造商
- 拉丁美洲市場規模與預測（依國家）
- 拉丁美洲市場規模與預測（依產品類型）
- 拉丁美洲市場規模和預測（依最終用途）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- E型肝炎診斷測試中東和非洲的主要製造商
- 中東和非洲市場規模及預測（依國家）
- 中東和非洲市場規模及預測（依產品類型）
- 中東和非洲市場規模和預測（依最終用途）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA其他地區

第10章主要供應商分析 - E型肝炎診斷測試產業

競爭儀表板
公司簡介
- Altona Diagnostics
- Dia.Pro Diagnostic Bioprobes srl
- ELITechGroup
- F. Hoffmann-La Roche Ltd
- Fortress Diagnostics
- Mikrogen GmbH
- MP Biomedicals LLP
- PerkinElmer, Inc
- Primerdesign Ltd
- Wantai BioPharm
- Others

第11章 360 度分析師視角

第12章附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV4064

REPORT HIGHLIGHT

Hepatitis E Diagnostic Tests Market size was valued at USD 53.52 Million in 2023, expanding at a CAGR of 4.80% from 2024 to 2032.

Hepatitis E diagnostic tests are medical assays designed to detect the presence of the Hepatitis E virus (HEV), which causes liver inflammation. These tests typically utilize serological methods to identify antibodies (anti-HEV IgM and IgG) or molecular techniques such as PCR polymerase chain reaction (PCR) to detect viral RNA. Early and accurate diagnosis is crucial for managing hepatitis E, especially in pregnant women and individuals with compromised liver function, as the infection can result in severe complications. Hepatitis E diagnostics play a vital role in public health monitoring and controlling outbreaks, particularly in regions where the virus is endemic.

Hepatitis E Diagnostic Tests Market- Market Dynamics

Increasing need of early diagnosis and timely treatment to propel market demand

The global market for hepatitis E diagnostics has experienced significant technological advancements in recent years, enhancing the accuracy, efficiency, and accessibility of diagnostic solutions. For instance, in June 2021, DiaSorin launched fully automated high-throughput CLIA solution for the hepatitis E diagnosis, available in countries that accept the CE mark. This new offering represents a important improvement in hepatitis E diagnostics, allowing healthcare providers to conduct high-throughput testing efficiently. This capability is particularly important in regions with high hepatitis E prevalence, where rapid identification of infected individuals is essential for effective disease management and prevention. The introduction of such advanced diagnostic platforms meets the growing demand for accurate and efficient testing solutions. Efforts to raise awareness among healthcare providers, at-risk populations, and the general public are also crucial in driving market growth. Increased awareness of the risks and consequences of hepatitis E, including higher mortality rates in pregnant women, is fueling demand for accurate diagnostic tests. The inclusion of hepatitis E tests in the WHO's 2023 Essential Diagnostics List highlights the global recognition of the importance of early detection and management of the disease. Governments and healthcare systems are increasingly acknowledging the need for improved surveillance and outbreak management, leading to greater procurement of HEV diagnostic kits. Additionally, patients and clinicians are seeking better access to hepatitis E tests to enable early diagnosis and timely treatment, further boosting market growth. For example, the Government of India's comprehensive National Viral Hepatitis Control Program aims to address the burden of all forms of viral hepatitis, including hepatitis E, through a multi-pronged approach focused on prevention, diagnosis, and treatment. This program involves significant government funding and a decentralized implementation strategy to enhance the healthcare system's capacity to manage viral hepatitis effectively. Increasing healthcare expenditure, particularly in emerging markets, is also supporting market growth. The emphasis on early detection and effective disease management is driving demand for diagnostic tests. As awareness about hepatitis E grows, there is a heightened focus on implementing preventive measures, including personal hygiene, safe water sources, proper sanitation, and food safety, to mitigate the virus's spread.

Hepatitis E Diagnostic Tests Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.80% over the forecast period (2024-2032)

Based on Product Type segmentation, ELISA HEV IgM test was predicted to show maximum market share in the year 2023

Based on End-use segmentation, the hospital was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Hepatitis E Diagnostic Tests Market- Segmentation Analysis:

The Global Hepatitis E Diagnostic Tests Market is segmented on the basis of Product Type, End-use, and Region.

The market is divided into four categories based on product type: ELISA HEV IgM Test, ELISA HEV IgG Test, Rapid Diagnostics Test and Polymerase Chain Reaction (PCR). Based on type, the ELISA HEV IgM test segment led the hepatitis E diagnostic tests market with the largest revenue share in 2023. This dominance is primarily due to the critical role of detecting IgM-class antibodies to the hepatitis E virus (HEV) for identifying acute or recent infections (less than six months). The presence of IgM antibodies is essential for diagnosing acute hepatitis E, typically confirmed by follow-up RNA testing. The high sensitivity and specificity of ELISA-based IgM tests make them the preferred option for initial HEV screening. For example, Dia.Pro offers the HEV-IgM ELISA test kit, specifically designed to detect IgM antibodies against HEV in human serum or plasma. The increasing incidence of hepatitis E infections, especially in developing regions with inadequate sanitation and hygiene practices, has significantly boosted the demand for effective diagnostic tools like the ELISA HEV IgM test.

The market is divided into four categories based on End use: Hospital, Blood Banks, Diagnostics Laboratories, and Other End User. In terms of end use, the hospital segment was leading the market with the largest revenue share in 2023. This trend is primarily driven by the high prevalence of hepatitis E cases being diagnosed and treated in hospitals globally. Hospitals are equipped with advanced diagnostic facilities, a diverse range of healthcare professionals, and the necessary infrastructure to efficiently diagnose and manage hepatitis E cases. Moreover, hospitals often act as referral centers for more complex cases, further enhancing their significant revenue share in the global market.

Hepatitis E Diagnostic Tests Market- Geographical Insights

This market caters to a geographically scattered customer base, spanning North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Participating nations within these regions create sub-segments within the market. The hepatitis E diagnostic tests market in North America accounted for a significant share in 2023. The region's well-established healthcare infrastructure, comprising hospitals, diagnostic laboratories, and research centers, supports market growth by providing a conducive environment for the adoption of diagnostic tests. Additionally, government initiatives and funding for research and development in infectious disease diagnostics contribute to market growth by facilitating the development and adoption of new diagnostic solutions. For instance, in April 2024, Dr. Susan Hafenstein of The Hormel Institute at the University of Minnesota received an $85,000 NIH-funded grant from Nationwide Children's Hospital to support her cryoEM research into HEV, with the goal of creating new treatments and prevention strategies for hepatitis E.

Hepatitis E Diagnostic Tests Market- Competitive Landscape:

Companies in the hepatitis E diagnostic tests market employ various strategies to enhance competitiveness and expand their market reach. Emphasizing research and development is crucial, with efforts focused on improving test sensitivity and specificity, as well as creating rapid and point-of-care testing solutions. Strategic collaborations with healthcare institutions and laboratories help facilitate clinical validation and promote the widespread adoption of new tests. Marketing strategies highlight the importance of early detection in preventing complications, specifically targeting healthcare providers and public health agencies. Additionally, companies frequently engage in educational initiatives to raise awareness about the risks of hepatitis E and the availability of testing, ensuring that diagnostics become an integral part of liver health management.

Recent Developments:

In November 2023, Roche introduced two automated immunoassays, the Elecsys Anti-HEV IgG and the Elecsys Anti-HEV IgM, designed to detect hepatitis E virus infections. These tests are available in countries that recognize the CE mark, including members of the European Union.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Altona Diagnostics
Dia.Pro Diagnostic Bioprobes srl
ELITechGroup
F. Hoffmann-La Roche Ltd
Fortress Diagnostics
Mikrogen GmbH
MP Biomedicals LLP
PerkinElmer, Inc
Primerdesign Ltd
Wantai BioPharm
Others

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

ELISA HEV IgM Test
ELISA HEV IgG Test
Rapid Diagnostics Test
Polymerase Chain Reaction (PCR)

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

Hospital
Diagnostics Laboratories
Blood Banks
Other End User

GLOBAL HEPATITIS E DIAGNOSTIC TESTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Hepatitis E Diagnostic Tests Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Hepatitis E Diagnostic Tests Market Snippet by Product Type
- 2.1.2. Hepatitis E Diagnostic Tests Market Snippet by End Use
- 2.1.3. Hepatitis E Diagnostic Tests Market Snippet by Country
- 2.1.4. Hepatitis E Diagnostic Tests Market Snippet by Region
2.2. Competitive Insights

3. Hepatitis E Diagnostic Tests Key Market Trends

3.1. Hepatitis E Diagnostic Tests Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Hepatitis E Diagnostic Tests Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Hepatitis E Diagnostic Tests Market Opportunities
3.4. Hepatitis E Diagnostic Tests Market Future Trends

4. Hepatitis E Diagnostic Tests Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Hepatitis E Diagnostic Tests Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Hepatitis E Diagnostic Tests Market Landscape

6.1. Hepatitis E Diagnostic Tests Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Hepatitis E Diagnostic Tests Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
- 7.1.2. ELISA HEV IgM Test
- 7.1.3. ELISA HEV IgG Test
- 7.1.4. Rapid Diagnostics Test
- 7.1.5. Polymerase Chain Reaction (PCR)

8. Hepatitis E Diagnostic Tests Market - By End Use

8.1. Overview
- 8.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
- 8.1.2. Hospital
- 8.1.3. Diagnostics Laboratories
- 8.1.4. Blood Banks
- 8.1.5. Other End User

9. Hepatitis E Diagnostic Tests Market- By Geography

9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
9.2. North America
- 9.2.1. Overview
- 9.2.2. Hepatitis E Diagnostic Tests Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.2.6. U.S.
  - 9.2.6.1. Overview
  - 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.2.6.4. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.2.7. Canada
  - 9.2.7.1. Overview
  - 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.2.7.4. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3. Europe
- 9.3.1. Overview
- 9.3.2. Hepatitis E Diagnostic Tests Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.6. Germany
  - 9.3.6.1. Overview
  - 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.6.4. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.7. Italy
  - 9.3.7.1. Overview
  - 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.7.4. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.8. United Kingdom
  - 9.3.8.1. Overview
  - 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.8.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.9. France
  - 9.3.9.1. Overview
  - 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.9.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.10. Russia
  - 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.10.3. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.11. Netherlands
  - 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.11.3. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.12. Sweden
  - 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.12.3. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.13. Poland
  - 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.13.3. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.14. Rest of Europe
  - 9.3.14.1. Overview
  - 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.3.14.4. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Hepatitis E Diagnostic Tests Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.6. India
  - 9.4.6.1. Overview
  - 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.6.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.6.4. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.7. China
  - 9.4.7.1. Overview
  - 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.7.4. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.8. Japan
  - 9.4.8.1. Overview
  - 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.8.4. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.9. South Korea
  - 9.4.9.1. Overview
  - 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.9.4. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.10. Australia
  - 9.4.10.1. Overview
  - 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.10.4. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.11. Thailand
  - 9.4.11.1. Overview
  - 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.11.4. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.12. Indonesia
  - 9.4.12.1. Overview
  - 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.12.4. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.13. Philippines
  - 9.4.13.1. Overview
  - 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.13.4. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.14. Rest of APAC
  - 9.4.14.1. Overview
  - 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.4.14.4. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Hepatitis E Diagnostic Tests Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.6. Brazil
  - 9.5.6.1. Overview
  - 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.6.4. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.7. Mexico
  - 9.5.7.1. Overview
  - 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.7.4. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.8. Argentina
  - 9.5.8.1. Overview
  - 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.8.4. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.9. Colombia
  - 9.5.9.1. Overview
  - 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.9.4. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.10. Rest of LATAM
  - 9.5.10.1. Overview
  - 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.5.10.4. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Hepatitis E Diagnostic Tests Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.6. Saudi Arabia
  - 9.6.6.1. Overview
  - 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.6.4. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.7. United Arab Emirates
  - 9.6.7.1. Overview
  - 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.7.4. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.8. Israel
  - 9.6.8.1. Overview
  - 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.8.4. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.9. Turkey
  - 9.6.9.1. Overview
  - 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.9.4. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.10. Algeria
  - 9.6.10.1. Overview
  - 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.10.4. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.11. Egypt
  - 9.6.11.1. Overview
  - 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.11.4. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.12. Rest of MEA
  - 9.6.12.1. Overview
  - 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 9.6.12.4. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Hepatitis E Diagnostic Tests Industry

10.1. Competitive Dashboard
10.2. Company Profiles
- 10.2.1. Altona Diagnostics
- 10.2.2. Dia.Pro Diagnostic Bioprobes srl
- 10.2.3. ELITechGroup
- 10.2.4. F. Hoffmann-La Roche Ltd
- 10.2.5. Fortress Diagnostics
- 10.2.6. Mikrogen GmbH
- 10.2.7. MP Biomedicals LLP
- 10.2.8. PerkinElmer, Inc
- 10.2.9. Primerdesign Ltd
- 10.2.10. Wantai BioPharm
- 10.2.11. Others